$3.46
-0.04-1.14%
Last update: Nov 4, 5:41 PM
LENZ Therapeutics Inc
LENZNASDAQ
The average analyst price target for LENZ Therapeutics is $29.13, 754.3% above the current price. Of 8 analysts, 7 rate it Buy and 1 Hold. Targets range from $5 to $50. The latest change came on Oct 30, 2026, when HC Wainwright & Co. lowered its price target on LENZ Therapeutics from $38 to $16 and kept a Buy rating.
Price Target Range — 12 Quarters
Analyst Consensus — 8 Analysts
Rating Trend — Last 9 Months
